Bio-Techne Corporation (FRA:TE1)

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of EUR 7.75 billion. The enterprise value is 7.96 billion.

Market Cap	7.75B
Enterprise Value	7.96B

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Nov 17, 2025

Share Statistics

Current Share Class	155.81M
Shares Outstanding	n/a
Shares Change (YoY)	-1.27%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	1.12%
Owned by Institutions (%)	105.48%
Float	153.94M

Valuation Ratios

The trailing PE ratio is 116.63 and the forward PE ratio is 28.77.

PE Ratio	116.63
Forward PE	28.77
PS Ratio	7.47
PB Ratio	4.62
P/TBV Ratio	14.28
P/FCF Ratio	40.57
P/OCF Ratio	36.18
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.72, with an EV/FCF ratio of 41.69.

EV / Earnings	119.83
EV / Sales	7.67
EV / EBITDA	26.72
EV / EBIT	35.33
EV / FCF	41.69

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.20.

Current Ratio	4.22
Quick Ratio	2.28
Debt / Equity	0.20
Debt / EBITDA	1.13
Debt / FCF	1.76
Interest Coverage	28.40

Financial Efficiency

Return on equity (ROE) is 3.80% and return on invested capital (ROIC) is 6.72%.

Return on Equity (ROE)	3.80%
Return on Assets (ROA)	6.25%
Return on Invested Capital (ROIC)	6.72%
Return on Capital Employed (ROCE)	11.05%
Revenue Per Employee	334,523
Profits Per Employee	21,431
Employee Count	3,100
Asset Turnover	0.46
Inventory Turnover	2.08

Taxes

In the past 12 months, Bio-Techne has paid 24.12 million in taxes.

Income Tax	24.12M
Effective Tax Rate	26.63%

Stock Price Statistics

The stock price has decreased by -30.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-30.14%
50-Day Moving Average	52.29
200-Day Moving Average	47.61
Relative Strength Index (RSI)	40.55
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.28

Income Statement

In the last 12 months, Bio-Techne had revenue of EUR 1.04 billion and earned 66.44 million in profits. Earnings per share was 0.41.

Revenue	1.04B
Gross Profit	693.09M
Operating Income	224.30M
Pretax Income	90.59M
Net Income	66.44M
EBITDA	277.24M
EBIT	224.30M
Earnings Per Share (EPS)	0.41

Balance Sheet

The company has 123.55 million in cash and 336.21 million in debt, giving a net cash position of -212.66 million.

Cash & Cash Equivalents	123.55M
Total Debt	336.21M
Net Cash	-212.66M
Net Cash Per Share	n/a
Equity (Book Value)	1.68B
Book Value Per Share	10.76
Working Capital	396.29M

Cash Flow

In the last 12 months, operating cash flow was 214.14 million and capital expenditures -23.18 million, giving a free cash flow of 190.96 million.

Operating Cash Flow	214.14M
Capital Expenditures	-23.18M
Free Cash Flow	190.96M
FCF Per Share	n/a

Margins

Gross margin is 66.84%, with operating and profit margins of 21.63% and 6.41%.

Gross Margin	66.84%
Operating Margin	21.63%
Pretax Margin	8.74%
Profit Margin	6.41%
EBITDA Margin	26.73%
EBIT Margin	21.63%
FCF Margin	18.41%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.59%.

Dividend Per Share	0.29
Dividend Yield	0.59%
Dividend Growth (YoY)	-3.37%
Years of Dividend Growth	n/a
Payout Ratio	64.30%
Buyback Yield	1.27%
Shareholder Yield	1.86%
Earnings Yield	0.86%
FCF Yield	2.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 30, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio-Techne has an Altman Z-Score of 12 and a Piotroski F-Score of 6.

Altman Z-Score	12
Piotroski F-Score	6